A novel glycosylation-related gene signature predicts survival in patients with lung adenocarcinoma

A novel glycosylation-related gene signature predicts survival in patients with lung adenocarcinoma

Abstract Background Lung adenocarcinoma (LUAD) is the most common malignant tumor that seriously affects human health. Previous studies have indicated that abnormal levels of glycosylation promote progression and poor prognosis of lung cancer. Thus, the present study aimed to explore the prognostic...

Full description

Bibliographic Details
Main Authors: Jin-xiao Liang, Qian Chen, Wei Gao, Da Chen, Xin-yu Qian, Jin-qiao Bi, Xing-chen Lin, Bing-bing Han, Jin-shi Liu
Format: Article
Language:English
Published: BMC 2022-12-01
Series:BMC Bioinformatics
Subjects:
Lung adenocarcinoma (LUAD)
Glycosyltransferases (GTs)
Prognosis
Immune cells
Online Access:https://doi.org/10.1186/s12859-022-05109-8

Internet

https://doi.org/10.1186/s12859-022-05109-8

Similar Items